Raymond James Financial Inc Aquestive Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 139,591 shares of AQST stock, worth $421,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,591Holding current value
$421,564% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
126Shares Held
47.3MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$29.6 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$16.8 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$12.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$8.35 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $161M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...